AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8785133 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study 1468273 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose diet (20% of energy from fructose)
Number of subjects: 18
Study 1468273 — intervention group
Group type: COMPARATOR
Intervention: Starch diet (<3% of energy from fructose)
Number of subjects: 18
Study 6387754 — intervention group
Group type: EXPERIMENTAL
Intervention: Social work intervention with attached social workers in general practice
Number of subjects: 80
Study 6387754 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment by their doctor (Control)
Number of subjects: 80
Study 6387754 — intervention group
Group type: EXPERIMENTAL
Intervention: Social work intervention
Number of subjects: 80
Study 29295652 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training
Number of subjects: 80
Study 29295652 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 80
Study 28415135 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage (twice a day for 14 days)
Number of subjects: 55
Study 28415135 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage
Number of subjects: 55
Study 28415135 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage (in feeding-intolerant subgroup)
Number of subjects: 55
Study 28415135 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise (control group)
Number of subjects: 55
Study 26935474 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio Feedback with Reduced Self-focus (AF with RS)
Number of subjects: 41
Study 26935474 — intervention group
Group type: COMPARATOR
Intervention: Audio Feedback only (AF only)
Number of subjects: 41
Study 26121801 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS group (1,500 ml ORS 6 to 2 hours before anesthesia)
Number of subjects: 20
Study 26121801 — intervention group
Group type: COMPARATOR
Intervention: Control group (nothing by mouth from 6 hours before anesthesia)
Number of subjects: 20
Study 22433176 — intervention group
Group type: EXPERIMENTAL
Intervention: OVK program (cognitive-behavioral and social problem-solving skills) delivered by trained school teachers during school hours.
Number of subjects: 1324
Study 22433176 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 1324
Study 22433176 — intervention group
Group type: EXPERIMENTAL
Intervention: OVK program (cognitive-behavioral and social problem-solving skills).
Number of subjects: 1324
Study 20299238 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum MCP-1 concentrations measured at baseline (mean 46 h), 12 weeks, and 24 weeks
Number of subjects: 100
Study 20299238 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum MCP-1 concentrations
Number of subjects: 100
Study 20299238 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-3, MMP-9, and MMP-2 concentrations measured at each time-point
Number of subjects: 100
Study 18417894 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% povidone‐iodine mouthwash
Number of subjects: 80
Study 18417894 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mouthwash)
Number of subjects: 80
Study 18417894 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt/soda mouthwash
Number of subjects: 80
Study 18417894 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 80
Study 16027631 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond Plus Self‐Etching Primer (3M Unitek)
Number of subjects: 22
Study 16027631 — intervention group
Group type: COMPARATOR
Intervention: One‐Step Self‐Etching Primer (Reliance)
Number of subjects: 22
Study 12012316 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO)
Number of subjects: 0
Study 12012316 — intervention group
Group type: COMPARATOR
Intervention: All‐trans retinoic acid (ATRA) and anthracycline‐based chemotherapy
Number of subjects: 0
Study 12012316 — intervention group
Group type: COMPARATOR
Intervention: ATRA-based regimens
Number of subjects: 0
Study 10713869 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide 150 micrograms kg‐1 and ondansetron 100 micrograms kg‐1
Number of subjects: 100
Study 10713869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 150 micrograms kg‐1
Number of subjects: 100
Study 10713869 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 250 micrograms kg‐1
Number of subjects: 100
Study 10713869 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 100
Study 8935189 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 96
Study 8935189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) intravenously
Number of subjects: 96
Study 8935189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) orally
Number of subjects: 96
Study 8935189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CSA)
Number of subjects: 96
Study 8935189 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 96
Study 1756217 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifluorid 12 (6% sodium fluoride and 6% calcium fluoride)
Number of subjects: 400
Study 1756217 — intervention group
Group type: EXPERIMENTAL
Intervention: Laweflour‐Schüttellack (5% sodium fluoride)
Number of subjects: 400
Study 1756217 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 400
Study 6384161 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole (2.0 gm/m2) with each of six fractions of 6.0 Gy in hyperbaric oxygen at 3 ATA
Number of subjects: 31
Study 6384161 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sensitizers (misonidazole and hyperbaric oxygen)
Number of subjects: 31
Study 6384161 — intervention group
Group type: COMPARATOR
Intervention: 63.0 Gy in 30 fractions in air (control group)
Number of subjects: 31
Study 30840831 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-rich platelet-rich plasma (LR-PRP) injection
Number of subjects: 80
Study 30840831 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 80
Study 30840831 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover group (previously failed CSI, treated with LR-PRP)
Number of subjects: 80
Study 29763594 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Paravertebral Block (PVB)
Number of subjects: 171
Study 29763594 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Patient-Controlled Analgesia (PCA)
Number of subjects: 171
Study 27506923 — intervention group
Group type: EXPERIMENTAL
Intervention: STAT model (Specific Timely Appointments for Triage)
Number of subjects: 0
Study 24695352 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz-containing regimen
Number of subjects: 360
Study 20131679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensodyne Pronamel (1450 ppm F as NaF/5% KNO3)
Number of subjects: 170
Study 20131679 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Cavity Protection (1100 ppm F as NaF)
Number of subjects: 170
Study 20131679 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Pro‐Health (0.454% SnF2 [1100 ppm F]/sodium hexametaphosphate)
Number of subjects: 170
Study 20131679 — intervention group
Group type: EXPERIMENTAL
Intervention: Blend‐a‐Med Classic (1450 ppm F as NaF)
Number of subjects: 170
Study 20131679 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Sensitive Multi Protection (1000 ppm F as NaMFP/5.53% potassium citrate/2% zinc citrate)
Number of subjects: 170
Study 20131679 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (0 ppm F)
Number of subjects: 170
Study 15026923 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic colectomy (HALC)
Number of subjects: 60
Study 15026923 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 60
Study 11288047 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid (NA) 7.4 mg.kg(‐1) body weight before exercise and 3.7 mg.kg(‐1) at 0 and 30 minutes of exercise
Number of subjects: 6
Study 11288047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 6
Study 9237961 — intervention group
Group type: COMPARATOR
Intervention: Olestra 0 g/d
Number of subjects: 90
Study 9237961 — intervention group
Group type: EXPERIMENTAL
Intervention: Olestra 8 g/d
Number of subjects: 90
Study 9237961 — intervention group
Group type: EXPERIMENTAL
Intervention: Olestra 20 g/d
Number of subjects: 90
Study 9237961 — intervention group
Group type: EXPERIMENTAL
Intervention: Olestra 32 g/d
Number of subjects: 90
Study 8422080 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment
Number of subjects: 82
Study 8422080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 3612781 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical-fitness evaluation (PF)
Number of subjects: 200
Study 3612781 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical-fitness evaluation and health-hazard appraisal (PF-HA)
Number of subjects: 200
Study 3612781 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 200
Study 3612781 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (HA)
Number of subjects: 200
Study 30910568 — intervention group
Group type: COMPARATOR
Intervention: Non-specific instruction ('do some [exercise]')
Number of subjects: 24
Study 30910568 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction A: 'do [exercise] 25 times'
Number of subjects: 24
Study 30910568 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction B: 'do [exercise] 25 times as fast as you can'
Number of subjects: 24
Study 30910568 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction C: 'do [exercise] 25 times, as fast as you can, aiming for a personal best'
Number of subjects: 24
Study 29948822 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg TNK‐tPA
Number of subjects: 112
Study 29948822 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg TNK‐tPA
Number of subjects: 112
Study 29948822 — intervention group
Group type: COMPARATOR
Intervention: NINDS trial (historical control)
Number of subjects: 112
Study 26825408 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal packing (P)
Number of subjects: 77
Study 26825408 — intervention group
Group type: COMPARATOR
Intervention: No vaginal packing (NP)
Number of subjects: 77
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Light Transmission Aggregometry (LTA) with 10 μmol ADP
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Verify Now P2Y12 (VN)
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilatator-stimulated phosphoprotein (VASP)
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between LTA and VN
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between LTA and VASP
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between VN and VASP
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-specified cut-off points for defining responders
Number of subjects: 100
Study 24176022 — intervention group
Group type: EXPERIMENTAL
Intervention: Single test poor responder definition
Number of subjects: 100
Study 22882714 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiprofessional team training in a medical simulation centre
Number of subjects: 74
Study 19263121 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure pneumoperitoneum (15 mmHg)
Number of subjects: 52
Study 19263121 — intervention group
Group type: COMPARATOR
Intervention: Low-pressure pneumoperitoneum (7 mmHg)
Number of subjects: 52
Study 17228023 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant fluorouracil (FU) treatment
Number of subjects: 542
Study 17228023 — intervention group
Group type: COMPARATOR
Intervention: Surgery-alone group (untreated cohort)
Number of subjects: 542
Study 15510093 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 32
Study 15510093 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroid injections
Number of subjects: 32
Study 15510093 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care education
Number of subjects: 32
Study 11417926 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 1
Study 11417926 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-channel EEG recording during ECT
Number of subjects: 1
Study 9627039 — intervention group
Group type: EXPERIMENTAL
Intervention: High-performance membranes (HPMs)
Number of subjects: 10
Study 7931862 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus Training and Employment Program (TEP)
Number of subjects: 250
Study 7931862 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 250
Study 7931862 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus TEP
Number of subjects: 250
Study 2967089 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 7.5 mg dose of SQ 27, 519
Number of subjects: 9
Study 2967089 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 10 mg doses of fosinopril sodium (capsule and solution)
Number of subjects: 9
Study 2967089 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral doses of fosinopril sodium
Number of subjects: 9
Study 31923341 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental vitamin D3 (2000 IU/d)
Number of subjects: 771
Study 31923341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 771
Study 29269149 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 20
Study 29269149 — intervention group
Group type: COMPARATOR
Intervention: No PRF (Control)
Number of subjects: 20
Study 27016629 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal worrying
Number of subjects: 125
Study 27016629 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-based worrying
Number of subjects: 125
Study 27016629 — intervention group
Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 125
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid diagnosis and treatment of IS
Number of subjects: 69
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: ADOS assessment
Number of subjects: 69
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic IS
Number of subjects: 69
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic epileptic discharges in frontotemporal areas
Number of subjects: 69
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-white origin
Number of subjects: 69
Study 25944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Early diagnosis and treatment
Number of subjects: 69
Study 23071247 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV plus RT
Number of subjects: 291
Study 23071247 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 291
Study 20185602 — intervention group
Group type: EXPERIMENTAL
Intervention: QW dosing of epoetin alfa
Number of subjects: 430
Study 20185602 — intervention group
Group type: EXPERIMENTAL
Intervention: Q2W dosing of epoetin alfa
Number of subjects: 430
Study 20185602 — intervention group
Group type: EXPERIMENTAL
Intervention: Q4W dosing of epoetin alfa
Number of subjects: 430
Study 18237394 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (200,000 IU) plus zinc (10 mg elemental zinc, six days a week)
Number of subjects: 148
Study 18237394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 16730929 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg)
Number of subjects: 50
Study 16730929 — intervention group
Group type: COMPARATOR
Intervention: EPT (1 mg 17beta‐estradiol + 0.5 mg NETA)
Number of subjects: 50
Study 14650366 — intervention group
Group type: EXPERIMENTAL
Intervention: nifuratel 125 mg/nystatin 50000 IU
Number of subjects: 60
Study 14650366 — intervention group
Group type: EXPERIMENTAL
Intervention: nifuratel 250 mg/nystatin 100000 IU
Number of subjects: 60
Study 14650366 — intervention group
Group type: EXPERIMENTAL
Intervention: nifuratel 500 mg/nystatin 200000 IU
Number of subjects: 60
Study 10736141 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis of a topical solution of 2% lidocaine with epinephrine 1:100,000
Number of subjects: 100
Study 10736141 — intervention group
Group type: COMPARATOR
Intervention: 2.5% lidocaine and 2.5% prilocaine (EMLA cream)
Number of subjects: 100
Study 9124845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftizoxime
Number of subjects: 12
Study 9124845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 12
Study 1551749 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand A of ciprofloxacin
Number of subjects: 0
Study 1551749 — intervention group
Group type: COMPARATOR
Intervention: Brand B of ciprofloxacin
Number of subjects: 0
Study 3157720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (NT) alone
Number of subjects: 35
Study 3157720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (NT) with cognitive therapy
Number of subjects: 35
Study 3157720 — intervention group
Group type: COMPARATOR
Intervention: Control group (mean plasma levels within therapeutic window)
Number of subjects: 35
Study 30884788 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss quartile 4 (average weight loss: -10.7%)
Number of subjects: 138
Study 29702652 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of H10407 at a dose of 105 CFU
Number of subjects: 30
Study 29702652 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of H10407 at a dose of 106 CFU
Number of subjects: 30
Study 29702652 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but implied as no treatment)
Number of subjects: 30
Study 29702652 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune responses measured (anti-LT toxin, CFA/I, LPS O78)
Number of subjects: 30
Study 29702652 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention for asymptomatic infections
Number of subjects: 30
Study 26395650 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive environmental distraction intervention (minimum, light, light and animation)
Number of subjects: 182
Study 26395650 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive environmental distraction intervention
Number of subjects: 182
Study 24659421 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention in preschools, including trainings, workshops, site visits, feedback, newsletters, and physical activity equipment.
Number of subjects: 8
Study 23074170 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment at a dose of 0.1 IU/kg/day for 14 days
Number of subjects: 25
Study 23074170 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH treatment
Number of subjects: 25
Study 20567613 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic alone
Number of subjects: 120
Study 20567613 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic and steroids
Number of subjects: 120
Study 20567613 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 120
Study 18019914 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft cast
Number of subjects: 117
Study 18019914 — intervention group
Group type: COMPARATOR
Intervention: Rigid cast
Number of subjects: 117
Study 16062080 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic lamivudine
Number of subjects: 37
Study 16062080 — intervention group
Group type: COMPARATOR
Intervention: Historical control (no lamivudine)
Number of subjects: 37
Study 12383806 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser trabeculoplasty (ALT)‐trabeculectomy‐trabeculectomy (ATT) sequence
Number of subjects: 591
Study 12383806 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy‐ALT‐trabeculectomy (TAT) sequence
Number of subjects: 591
Study 12383806 — intervention group
Group type: EXPERIMENTAL
Intervention: ATT sequence
Number of subjects: 591
Study 12383806 — intervention group
Group type: EXPERIMENTAL
Intervention: TAT sequence
Number of subjects: 591
Study 9527303 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized practices
Number of subjects: 0
Study 9527303 — intervention group
Group type: EXPERIMENTAL
Intervention: Few practices randomized
Number of subjects: 0
Study 8580280 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg q.d.s. for 1 week
Number of subjects: 20
Study 8580280 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg t.d.s. for 1 week
Number of subjects: 20
Study 1978070 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of serum and urinary aspergillus antigen
Number of subjects: 121
Study 696787 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction by specially trained clinical teaching associates (professional patients and teachers)
Number of subjects: 100
Study 696787 — intervention group
Group type: COMPARATOR
Intervention: Control group received practical instruction on office or clinic patients
Number of subjects: 100
Study 31129370 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions aimed at improving glucose control
Number of subjects: 90
Study 31129370 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions aimed at optimizing use of diabetes devices
Number of subjects: 90
Study 31129370 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally tailored behavioral supports with education
Number of subjects: 90
Study 31129370 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential multiple assignment randomization trial (SMART) design
Number of subjects: 90
Study 28637065 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning group
Number of subjects: 395
Study 28637065 — intervention group
Group type: COMPARATOR
Intervention: non-e-learning group
Number of subjects: 395
Study 25600619 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Marsh group
Number of subjects: 280
Study 25600619 — intervention group
Group type: COMPARATOR
Intervention: Schnider group
Number of subjects: 280